US Company Behind Teflon Tries to Block EU’s Forever Chemicals Ban, Claims NGO

Chemours, a significant American chemical company, spun off from DuPont, has been found to have lobbied massively against the proposed phase-out of PFAS chemicals by the European Union, widely referred to as "forever chemicals." As recently reported by the non-profit Corporate Europe Observatory (CEO), Chemours met with the EU Commission at higher levels than any other company, more than doubling its lobbying spend over the last year. The move comes at a time when there has been growing alarm over the potential environmental and health risks posed by PFAS, which are associated with cancers, liver damage, and a decrease in fertility.

This piece explores Chemours' lobbying practices, the significance of PFAS use, and the industry response to the plan to ban it.

What are PFAS, and why do they raise controversy?

Per- and polyfluoroalkyl substances, commonly abbreviated as PFAS, are synthetic chemicals used in a wide array of consumer and industrial products including:

Non-stick cookware (such as Teflon)
Waterproof clothing and sportswear
Semiconductors and batteries
Food packaging
Medical devices

PFAS has been termed a "forever chemical" due to its natural resistance to environmental degradation. Trace amounts of the chemicals have also been found in rainwater, breast milk, human brain tissue, and soil samples. Exposure has been linked with severe health consequences, such as:

Cancer risk

Damage to the liver and kidneys

Hormone disruption

Reproductive impairment

Developmental difficulties in children

With these concerns in mind, the European Union is set to impose a broad ban on PFAS, a move that could significantly affect industries relying on these chemicals.

Chemours' Lobbying Against the Ban

Increased Lobbying Activities

The CEO report reveals that Chemours has dramatically increased its lobbying in the EU, with lobby expenditures declared to be more than doubled in the past year. It has reportedly had six high-level meetings with the European Commission, making it the most active corporate entity opposing the PFAS ban.

Tactics Used

Chemours has used a variety of tactics to influence EU policymakers, including:

Mobilizing other industries: Companies relying on PFAS are being urged to lobby the Commission not to implement stringent regulations.

Promotion of weaker alternatives: Advancement of a more lenient regulatory strategy rather than a complete ban.

Conversible dealings with the Commission's departments: The company has consulted with authorities in several EU regulatory departments, including the Directorate-General for Research and Innovation, claiming that an outright ban on PFAS risks investments in green hydrogen and other new technologies.

Quotes from Chemours

Chemours responded to the allegations by saying that it is "committed to Europe and its future Clean Industrial Deal" and that it has no intention of slowing down the regulatory process. The company argues that, like NGOs and other stakeholders, businesses should have a say in policy decisions, providing "information, data, facts, and positions" to regulators.

Industry and Political Reactions

German Industry's Opposition

Germany is an important country with a powerful chemical industry and has expressed objections to the outright ban. States that have more industries believe that a complete phase-out will destroy crucial manufacturing industries, such as:

Semiconductor manufacturing
Renewable energy technologies
Automotive manufacturing
The German government has called for exemptions for certain uses that would permit the continued use of PFAS.

European Commission Position

Despite corporate lobbying pressure, the European Commission has maintained its commitment to the phase-out of PFAS. Policymakers argue that public health and environmental protection take precedence over industrial interests.

Chemours History of PFAS Controversies

Chemours has a long history of legal battles and environmental concerns regarding PFAS:

Legal Cases in the Netherlands: The company has been held liable for PFAS contamination in four Dutch municipalities.

Environmental Damage Scandal for Chemours in France
Chemours is being targeted on environmental issues brought about by pollution in Villers-Saint-Paul, an industrial town in France.

Background on DuPont: Chemours is a spinoff of DuPont, which was at the heart of a huge scandal surrounding PFAS pollution in the United States, as portrayed in the movie Dark Waters, starring Mark Ruffalo.

EU's Future on the PFAS Ban
Next Steps on EU's PFAS Ban Policy

It has been reviewing stakeholder input comprising industrialists, NGOs, and other scientific groups. The ban on PFAS is expected sometime in the following years, and the pressure applied by companies such as Chemours will likely alter some of the final proposals.

Impacts on Consumers and Industries:

Industries relying on PFAS would have to move to alternative materials if the EU goes ahead with its total ban. Many safer alternatives do exist, but it will still take a tremendous amount of investment and technological innovation to transition out of PFAS.

FAQs

What are PFAS known as "forever chemicals"?

PFAS are called "forever chemicals" because they do not degrade naturally in the environment. Instead, they continue to persist in water, soil, and even human tissues for decades.

What health risks are associated with PFAS exposure?

Exposure to PFAS has been linked to various health problems, including cancer, liver disease, hormonal disruptions, and decreased fertility.

What products contain PFAS?

PFAS are used in non-stick cookware, waterproof clothing, food packaging, firefighting foams, semiconductors, and many industrial applications.

What is Chemours' role in the PFAS controversy?

Chemours is actively lobbying against the EU's proposed PFAS ban. It has held numerous meetings with policymakers and increased its lobbying expenditure to influence regulatory decisions.

What happens if the EU bans PFAS?

If the EU enforces a strict ban, industries will need to transition to alternative materials. Some companies may face economic challenges, but the move could significantly benefit environmental and public health.

The battle for PFAS regulation in the EU is indicative of a greater battle between industrial interests and environmental safety. In the argument advanced by Chemours and other companies that a ban might disrupt essential industries, the risks to health and human well-being associated with PFAS are glaring. The future of businesses, consumers, and public health depends on the European regulators' final decision.

The coming years will reveal whether the EU prioritizes environmental protection over industrial convenience or if corporate lobbying efforts will dilute the proposed restrictions on "forever chemicals."